Petar Alaupovic

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Disorders

Concepts & Ideas

Risk Factors

Procedures

Double-Blind Method

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Sacks Frank M; Rudel Lawrence L; Conner Adam; Akeefe Hassibullah; Kostner Gerhard; Baki Talal; Rothblat George; de la Llera-Moya Margarita; Asztalos Bela; Perlman Timothy; Zheng Chunyu; Alaupovic Petar; Maltais Jo-Ann B; Brewer H Bryan
Selective delipidation of plasma HDL enhances reverse cholesterol transport in vivo.
Hodis Howard N; Mack Wendy J; Dustin Laurie; Mahrer Peter R; Azen Stanley P; Detrano Robert; Selhub Jacob; Alaupovic Petar; Liu Chao-ran; Liu Ci-hua; Hwang Juliana; Wilcox Alison G; Selzer Robert H;
High-dose B vitamin supplementation and progression of subclinical atherosclerosis: a randomized controlled trial.
Lee D M; Alaupovic P; Knight-Gibson C; Bagdade J D
Apolipoprotein-B subclasses as acceptors of cholesteryl esters transferred by CETP.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Petar Alaupovic (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Sacks Frank M; Rudel Lawrence L; Conner Adam; Akeefe Hassibullah; Kostner Gerhard; Baki Talal; Rothblat George; de la Llera-Moya Margarita; Asztalos Bela; Perlman Timothy; Zheng Chunyu; Alaupovic Petar; Maltais Jo-Ann B; Brewer H Bryan
Selective delipidation of plasma HDL enhances reverse cholesterol transport in vivo.
Journal of lipid research 2009;50(5):894-907.
2009: Hodis Howard N; Mack Wendy J; Dustin Laurie; Mahrer Peter R; Azen Stanley P; Detrano Robert; Selhub Jacob; Alaupovic Petar; Liu Chao-ran; Liu Ci-hua; Hwang Juliana; Wilcox Alison G; Selzer Robert H;
High-dose B vitamin supplementation and progression of subclinical atherosclerosis: a randomized controlled trial.
Stroke; a journal of cerebral circulation 2009;40(3):730-6.
2008: Lee D M; Alaupovic P; Knight-Gibson C; Bagdade J D
Apolipoprotein-B subclasses as acceptors of cholesteryl esters transferred by CETP.
European journal of clinical investigation 2008;38(10):734-42.
2008: Gebauer Sarah K; West Sheila G; Kay Colin D; Alaupovic Petar; Bagshaw Deborah; Kris-Etherton Penny M
Effects of pistachios on cardiovascular disease risk factors and potential mechanisms of action: a dose-response study.
The American journal of clinical nutrition 2008;88(3):651-9.
2008: Alaupovic Petar; Blackett Piers; Wang Wenyu; Lee Elisa
Characterization of the metabolic syndrome by apolipoproteins in the Oklahoma Cherokee.
Journal of the cardiometabolic syndrome 2008;3(4):193-9.
2007: Hilpert Kirsten F; West Sheila G; Kris-Etherton Penny M; Hecker Kari D; Simpson Nancy M; Alaupovic Petar
Postprandial effect of n-3 polyunsaturated fatty acids on apolipoprotein B-containing lipoproteins and vascular reactivity in type 2 diabetes.
The American journal of clinical nutrition 2007;85(2):369-76.
2006: Hodis Howard N; Mack Wendy J; Zheng Ling; Li Yanjie; Torres Mina; Sevilla Diego; Stewart Yolanda; Hollen Barbara; Garcia Karla; Alaupovic Petar; Buchanan Thomas A
Effect of peroxisome proliferator-activated receptor gamma agonist treatment on subclinical atherosclerosis in patients with insulin-requiring type 2 diabetes.
Diabetes care 2006;29(7):1545-53.
2006: Alaupovic P; Attman P-O; Knight-Gibson C; Mulec H; Weiss L; Samuelsson O
Effect of fluvastatin on apolipoprotein-defined lipoprotein subclasses in patients with chronic renal insufficiency.
Kidney international 2006;69(10):1865-71.
2005: Blackett Piers R; Blevins Kathleen S; Stoddart Martha; Wang Wenyu; Quintana Elaine; Alaupovic Petar; Lee Elisa T
Body mass index and high-density lipoproteins in Cherokee Indian children and adolescents.
Pediatric research 2005;58(3):472-7.
2005: Wang Wenyu; Lee Elisa T; Alaupovic Petar; Blackett Piers; Blevins Kathleen S
Correlation between lipoprotein(a) and other risk factors for cardiovascular disease and diabetes in Cherokee Indians: the Cherokee Diabetes Study.
Annals of epidemiology 2005;15(5):390-7.
2005: Kwiterovich Peter O; Cockrill Steven L; Virgil Donna G; Garrett Elizabeth S; Otvos James; Knight-Gibson Carolyn; Alaupovic Petar; Forte Trudy; Zhang Lin; Farwig Zachlyn N; Macfarlane Ronald D
A large high-density lipoprotein enriched in apolipoprotein C-I: a novel biochemical marker in infants of lower birth weight and younger gestational age.
JAMA : the journal of the American Medical Association 2005;293(15):1891-9.
2005: Blackett Piers R; Blevins Kathleen S; Quintana Elaine; Stoddart Martha; Wang Wenyu; Alaupovic Petar; Lee Elisa T
ApoC-III bound to apoB-containing lipoproteins increase with insulin resistance in Cherokee Indian youth.
Metabolism: clinical and experimental 2005;54(2):180-7.
2004: Lee Elisa T; Begum Momotaz; Wang Wenyu; Blackett Piers R; Blevins Kathleen S; Stoddart Martha; Tolbert Bernadine; Alaupovic Petar
Type 2 diabetes and impaired fasting glucose in American Indians aged 5-40 years: the Cherokee diabetes study.
Annals of epidemiology 2004;14(9):696-704.
2004: Kolmakova Antonina; Kwiterovich Peter; Virgil Donna; Alaupovic Petar; Knight-Gibson Carolyn; Martin Sergio F; Chatterjee Subroto
Apolipoprotein C-I induces apoptosis in human aortic smooth muscle cells via recruiting neutral sphingomyelinase.
Arteriosclerosis, thrombosis, and vascular biology 2004;24(2):264-9.
2003: Alaupovic Petar
The concept of apolipoprotein-defined lipoprotein families and its clinical significance.
Current atherosclerosis reports 2003;5(6):459-67.
2003: Lindholm Lars H; Persson Mats; Alaupovic Petar; Carlberg Bo; Svensson Anders; Samuelsson Ola
Metabolic outcome during 1 year in newly detected hypertensives: results of the Antihypertensive Treatment and Lipid Profile in a North of Sweden Efficacy Evaluation (ALPINE study).
Journal of hypertension 2003;21(8):1563-74.
2003: Attman Per-Ola; Samuelsson Ola; Johansson Ann-Cathrine; Moberly James B; Alaupovic Petar
Dialysis modalities and dyslipidemia.
Kidney international. Supplement 2003;(84):S110-2.
2003: Blackett Piers R; Germany Robin; Sambo Boureima; Alaupovic Petar
Apolipoprotein C-III bound to apolipoprotein B-containing lipoproteins in obese girls.
Clinical chemistry 2003;49(2):303-6.
2002: Hannuksela Minna L; Brousseau Margaret E; Meyn Susan M; Nazih Hassan; Bader Giovanni; Shamburek Robert D; Alaupovic Petar; Brewer H Bryan
In vivo metabolism of apolipoprotein E within the HDL subpopulations LpE, LpE:A-I, LpE:A-II and LpE:A-I:A-II.
Atherosclerosis 2002;165(2):205-20.
2002: Sacks Frank M; Alaupovic Petar; Moye Lemuel A
Effect of pravastatin on apolipoproteins B and C-III in very-low-density lipoproteins and low-density lipoproteins.
The American journal of cardiology 2002;90(2):165-7.
2002: Schweitzer Morris; Tessier Daniel; Vlahos William D; Leiter Lawrence; Collet Jean Paul; McQueen Matthew J; Harvey Laurent; Alaupovic Petar
A comparison of pravastatin and gemfibrozil in the treatment of dyslipoproteinemia in patients with non-insulin-dependent diabetes mellitus.
Atherosclerosis 2002;162(1):201-10.
2002: Moberly James B; Attman Per-Ola; Samuelsson Ola; Johansson Ann-Cathrine; Knight-Gibson Carolyn; Alaupovic Petar
Alterations in lipoprotein composition in peritoneal dialysis patients.
Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis 2002;22(2):220-8.
2002: Singh Atam B; Hsia Stanley; Alaupovic Petar; Sinha-Hikim Indrani; Woodhouse Linda; Buchanan Thomas A; Shen Ruoquing; Bross Rachelle; Berman Nancy; Bhasin Shalender
The effects of varying doses of T on insulin sensitivity, plasma lipids, apolipoproteins, and C-reactive protein in healthy young men.
The Journal of clinical endocrinology and metabolism 2002;87(1):136-43.
2002: Lee Diana M; Knight-Gibson Carolyn; Samuelsson Ola; Attman Per-Ola; Wang Chi-Sun; Alaupovic Petar
Lipoprotein particle abnormalities and the impaired lipolysis in renal insufficiency.
Kidney international 2002;61(1):209-18.
2002: Samuelsson Ola; Attman Per-Ola; Knight-Gibson Carolyn; Mulec Henrik; Weiss Lars; Alaupovic Petar
Fluvastatin improves lipid abnormalities in patients with moderate to advanced chronic renal insufficiency.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2002;39(1):67-75.
2001: Ottosson P; Attman P O; Knight C; Samuelsson O; Weiss L; Alaupovic P
Do high-flux dialysis membranes affect renal dyslipidemia?
ASAIO journal (American Society for Artificial Internal Organs : 1992) 2001;47(3):229-34.
2000: Sacks F M; Alaupovic P; Moye L A; Cole T G; Sussex B; Stampfer M J; Pfeffer M A; Braunwald E
VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the Cholesterol and Recurrent Events (CARE) trial.
Circulation 2000;102(16):1886-92.
2000: Alaupovic P
Management of dyslipidemia after coronary artery bypass grafting.
Current opinion in lipidology 2000;11(4):369-75.
2000: Johansson A C; Samuelsson O; Attman P O; Haraldsson B; Moberly J; Knight-Gibson C; Alaupovic P
Dyslipidemia in peritoneal dialysis--relation to dialytic variables.
Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis 2000;20(3):306-14.
1999: Alaupovic P; Fesmire J D; Hunnighake D; Domanski M; Forman S; Knatterud G L; Forrester J; Herd J A; Hoogwerf B; Campeau L; Gobel F L
The effect of aggressive and moderate lowering of LDL-cholesterol and low dose anticoagulation on plasma lipids, apolipoproteins and lipoprotein families in post coronary artery bypass graft trial.
Atherosclerosis 1999;146(2):369-79.
1999: Moberly J B; Attman P O; Samuelsson O; Johansson A C; Knight-Gibson C; Alaupovic P
Apolipoprotein C-III, hypertriglyceridemia and triglyceride-rich lipoproteins in uremia.
Mineral and electrolyte metabolism 1999;25(4-6):258-62.
1999: Attman P O; Alaupovic P; Samuelsson O
Lipoprotein abnormalities as a risk factor for progressive nondiabetic renal disease.
Kidney international. Supplement 1999;71():S14-7.
1999: Hodis H N; Mack W J; Krauss R M; Alaupovic P
Pathophysiology of triglyceride-rich lipoproteins in atherothrombosis: clinical aspects.
Clinical cardiology 1999;22(6 Suppl):II15-20.
1999: Pesant Y; Marc-Aurèle J; Bielmann P; Alaupovic P; Cartier P; Bichet D; Thibault G; Lupien P J
Metabolic and antihypertensive effects of nebivolol and atenolol in normometabolic patients with mild-to-moderate hypertension.
American journal of therapeutics 1999;6(3):137-47.
1999: Attman P O; Samuelsson O G; Moberly J; Johansson A C; Ljungman S; Weiss L G; Knight-Gibson C; Alaupovic P
Apolipoprotein B-containing lipoproteins in renal failure: the relation to mode of dialysis.
Kidney international 1999;55(4):1536-42.
1999: Samuelsson O; Lee D M; Attman P O; Knight-Gibson C; Mullen J K; Larsson R; Mulec H; Weiss L; Alaupovic P
The plasma levels of homocysteine are elevated in moderate renal insufficiency but do not predict the rate of progression.
Nephron 1999;82(4):306-11.
1998: Attman P O; Knight-Gibson C; Tavella M; Samuelsson O; Alaupovic P
The compositional abnormalities of lipoproteins in diabetic renal failure.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1998;13(11):2833-41.
1998: Samuelsson O; Attman P O; Knight-Gibson C; Larsson R; Mulec H; Weiss L; Alaupovic P
Complex apolipoprotein B-containing lipoprotein particles are associated with a higher rate of progression of human chronic renal insufficiency.
Journal of the American Society of Nephrology : JASN 1998;9(8):1482-8.
1998: Alaupovic P
Use of apolipoprotein parameters and endpoints in drug development and approval processes.
The American journal of cardiology 1998;81(8A):40F-47F.
1997: Attman P O; Samuelsson O; Alaupovic P
Progression of renal failure: role of apolipoprotein B-containing lipoproteins.
Kidney international. Supplement 1997;63():S98-101.
1997: Ooi T C; Heinonen T; Alaupovic P; Davignon J; Leiter L; Lupien P J; Sniderman A D; Tan M H; Tremblay G; Sorisky A; Shurzinske L; Black D M
Efficacy and safety of a new hydroxymethylglutaryl-coenzyme A reductase inhibitor, atorvastatin, in patients with combined hyperlipidemia: comparison with fenofibrate.
Arteriosclerosis, thrombosis, and vascular biology 1997;17(9):1793-9.
1997: Samuelsson O; Mulec H; Knight-Gibson C; Attman P O; Kron B; Larsson R; Weiss L; Wedel H; Alaupovic P
Lipoprotein abnormalities are associated with increased rate of progression of human chronic renal insufficiency.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1997;12(9):1908-15.
1997: Alaupovic P; Heinonen T; Shurzinske L; Black D M
Effect of a new HMG-CoA reductase inhibitor, atorvastatin, on lipids, apolipoproteins and lipoprotein particles in patients with elevated serum cholesterol and triglyceride levels.
Atherosclerosis 1997;133(1):123-33.
1997: Corder C N; Tavella M; McConathy W; Alaupovic P; Johnson M
Effect of probucol therapy on plasma fatty acid composition during postprandial lipemia in hypertriglyceridemia.
American journal of therapeutics 1997;4(7-8):247-54.
1997: Alaupovic P; Mack W J; Knight-Gibson C; Hodis H N
The role of triglyceride-rich lipoprotein families in the progression of atherosclerotic lesions as determined by sequential coronary angiography from a controlled clinical trial.
Arteriosclerosis, thrombosis, and vascular biology 1997;17(4):715-22.
1997: Attman P O; Samuelsson O; Alaupovic P
Lipid abnormalities in progressive renal insufficiency.
Contributions to nephrology 1997;120():1-10.
1997: Samuelsson O; Attman P O; Knight-Gibson C; Kron B; Larsson R; Mulec H; Weiss L; Alaupovic P
Effect of gemfibrozil on lipoprotein abnormalities in chronic renal insufficiency: a controlled study in human chronic renal disease.
Nephron 1997;75(3):286-94.
1996: Samuelsson O; Attman P O; Knight-Gibson C; Larsson R; Mulec H; Wedel H; Weiss L; Alaupovic P
Plasma levels of lipoprotein (a) do not predict progression of human chronic renal failure.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1996;11(11):2237-43.
1996: Koren E; Corder C; Mueller G; Centurion H; Hallum G; Fesmire J; McConathy W D; Alaupovic P
Triglyceride enriched lipoprotein particles correlate with the severity of coronary artery disease.
Atherosclerosis 1996;122(1):105-15.
1996: Hodis H N; Mack W J; LaBree L; Selzer R H; Liu C; Liu C; Alaupovic P; Kwong-Fu H; Azen S P
Reduction in carotid arterial wall thickness using lovastatin and dietary therapy: a randomized controlled clinical trial.
Annals of internal medicine 1996;124(6):548-56.
1996: Attman P O; Alaupovic P; Tavella M; Knight-Gibson C
Abnormal lipid and apolipoprotein composition of major lipoprotein density classes in patients with chronic renal failure.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1996;11(1):63-9.
1996: Alaupovic P
Significance of apolipoproteins for structure, function, and classification of plasma lipoproteins.
Methods in enzymology 1996;263():32-60.
1996: Attman P O; Samuelsson O; Alaupovic P
Diagnosis and classification of dyslipidemia in renal disease.
Blood purification 1996;14(1):49-57.
1995: Shircore A M; Mack W J; Selzer R H; Lee P L; Azen S P; Alaupovic P; Hodis H N
Compensatory vascular changes of remote coronary segments in response to lesion progression as observed by sequential angiography from a controlled clinical trial.
Circulation 1995;92(9):2411-8.
1995: Lane D M; Alaupovic P; Knight-Gibson C; Dudley V S; Laughlin L O
Changes in plasma lipid and apolipoprotein levels between heparin-induced extracorporeal low-density lipoprotein precipitation (HELP) treatments.
The American journal of cardiology 1995;75(16):1124-9.
1994: Alaupovic P; Hodis H N; Knight-Gibson C; Mack W J; LaBree L; Cashin-Hemphill L; Corder C N; Kramsch D M; Blankenhorn D H
Effects of lovastatin on ApoA- and ApoB-containing lipoproteins. Families in a subpopulation of patients participating in the Monitored Atherosclerosis Regression Study (MARS).
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1994;14(12):1906-13.
1994: Hodis H N; Mack W J; Azen S P; Alaupovic P; Pogoda J M; LaBree L; Hemphill L C; Kramsch D M; Blankenhorn D H
Triglyceride- and cholesterol-rich lipoproteins have a differential effect on mild/moderate and severe lesion progression as assessed by quantitative coronary angiography in a controlled trial of lovastatin.
Circulation 1994;90(1):42-9.
1994: Samuelsson O; Attman P O; Knight-Gibson C; Kron B; Larsson R; Mulec H; Weiss L; Alaupovic P
Lipoprotein abnormalities without hyperlipidaemia in moderate renal insufficiency.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1994;9(11):1580-5.
1993: Blankenhorn D H; Azen S P; Kramsch D M; Mack W J; Cashin-Hemphill L; Hodis H N; DeBoer L W; Mahrer P R; Masteller M J; Vailas L I; Alaupovic P; Hirsch L J;
Coronary angiographic changes with lovastatin therapy. The Monitored Atherosclerosis Regression Study (MARS).
Annals of internal medicine 1993;119(10):969-76.
1993: Blankenhorn D H; Selzer R H; Crawford D W; Barth J D; Liu C R; Liu C H; Mack W J; Alaupovic P
Beneficial effects of colestipol-niacin therapy on the common carotid artery. Two- and four-year reduction of intima-media thickness measured by ultrasound.
Circulation 1993;88(1):20-8.
1993: Attman P O; Samuelsson O; Alaupovic P
Lipoprotein metabolism and renal failure.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1993;21(6):573-92.
1993: Bekaert E D; Alaupovic P; Knight-Gibson C S; Franceschini G; Sirtori C R
Apolipoprotein A-I Milano: sex-related differences in the concentration and composition of apoA-I- and apoB-containing lipoprotein particles.
Journal of lipid research 1993;34(1):111-23.
1993: Samuelsson O; Aurell M; Knight-Gibson C; Alaupovic P; Attman P O
Apolipoprotein-B-containing lipoproteins and the progression of renal insufficiency.
Nephron 1993;63(3):279-85.
1992: Attman P O; Nyberg G; William-Olsson T; Knight-Gibson C; Alaupovic P
Dyslipoproteinemia in diabetic renal failure.
Kidney international 1992;42(6):1381-9.
1992: Wild R A; Alaupovic P; Givens J R; Parker I J
Lipoprotein abnormalities in hirsute women. II. Compensatory responses of insulin resistance and dehydroepiandrosterone sulfate with obesity.
American journal of obstetrics and gynecology 1992;167(6):1813-8.
1992: Alaupovic P; Bard J M; Tavella M; Shafer D
Identification of apoB-containing lipoprotein families in NIDDM.
Diabetes 1992;41 Suppl 2():18-25.
1992: Attman P O; Alaupovic P
Dietary treatment of uraemia and the relation to lipoprotein metabolism.
European journal of clinical nutrition 1992;46(10):687-96.
1992: Koren E; Armstrong V W; Mueller G; Wilson P R; Schuff-Werner P; Thiery J; Eisenhauer T; Alaupovic P; Seidel D
Apolipoprotein A-I and apolipoprotein B containing lipoprotein particles in coronary patients treated with extracorporal low density lipoprotein precipitation (HELP).
Atherosclerosis 1992;95(2-3):157-70.
1992: Bekaert E D; Alaupovic P; Knight-Gibson C; Norum R A; Laux M J; Ayrault-Jarrier M
Isolation and partial characterization of lipoprotein A-II (LP-A-II) particles of human plasma.
Biochimica et biophysica acta 1992;1126(1):105-13.
1992: Wild R A; Alaupovic P; Parker I J
Lipid and apolipoprotein abnormalities in hirsute women. I. The association with insulin resistance.
American journal of obstetrics and gynecology 1992;166(4):1191-6; discussion 1196-7.
1992: Corder C N; Goldberg M R; Alaupovic P A; Price M D; Furste S S
Lipid and apolipoprotein levels during therapy with pinacidil combined with hydrochlorothiazide.
European journal of clinical pharmacology 1992;42(1):65-70.
1992: Attman P O; Tavella M; Knight-Gibson C; Samuelsson O; Alaupovic P
Apolipoprotein B-containing lipoprotein particles in progressive renal insufficiency.
Contributions to nephrology 1992;98():11-9.
1992: Attman P O; Knight-Gibson C; Tavella M; Samuelsson O; Alaupovic P
Increased concentrations of Apo B-containing triglyceride-rich lipoprotein particles in patients with chronic renal failure.
Mineral and electrolyte metabolism 1992;18(2-5):199-202.
1991: Bekaert E D; Alaupovic P; Knight-Gibson C S; Laux M J; Pelachyk J M; Norum R A
Characterization of apoA- and apoB-containing lipoprotein particles in a variant of familial apoA-I deficiency with planar xanthoma: the metabolic significance of LP-A-II particles.
Journal of lipid research 1991;32(10):1587-99.
1991: Attman P O; Alaupovic P
Lipid abnormalities in chronic renal insufficiency.
Kidney international. Supplement 1991;31():S16-23.
1991: Bekaert E D; Alaupovic P; Knight-Gibson C; Blackett P; Ayrault-Jarrier M
Composition of plasma ApoA-I-containing lipoprotein particles in children and adults.
Pediatric research 1991;29(3):315-21.
1991: Alaupovic P; Knight-Gibson C; Wang C S; Downs D; Koren E; Brewer H B; Gregg R E
Isolation and characterization of an apoA-II-containing lipoprotein (LP-A-II:B complex) from plasma very low density lipoproteins of patients with Tangier disease and type V hyperlipoproteinemia.
Journal of lipid research 1991;32(1):9-19.
1991: Attman P O; Alaupovic P
Lipid and apolipoprotein profiles of uremic dyslipoproteinemia--relation to renal function and dialysis.
Nephron 1991;57(4):401-10.
1991: Alaupovic P; Blackenhorn D H; Knight-Gibson C; Tavella M; Bard J M; Shafer D; Lee E T; Brasuell J
apoB-containing lipoprotein particles as risk factors for coronary artery disease.
Advances in experimental medicine and biology 1991;285():299-309.
1991: Attman P O; Alaupovic P
Abnormalities of lipoprotein composition in renal insufficiency.
Progress in lipid research 1991;30(2-3):275-9.
1991: Tavella M; Alaupovic P; Knight-Gibson C; Tournier H; Schinella G; Mercuri O
Separation of ApoA- and ApoB-containing lipoproteins of human plasma by affinity chromatography on concanavalin A.
Progress in lipid research 1991;30(2-3):181-7.
1991: Bekaert E D; Alaupovic P; Knight-Gibson C; Ayrault-Jarrier M
The lipoprotein A-II (LP-A-II) family in normolipidemic subjects and patients with ApoA-I deficiency.
Progress in lipid research 1991;30(2-3):151-7.
1991: Alaupovic P
Apolipoprotein composition as the basis for classifying plasma lipoproteins. Characterization of ApoA- and ApoB-containing lipoprotein families.
Progress in lipid research 1991;30(2-3):105-38.
1990: Koren E; Franzen J; Fugate R D; Alaupovic P
Analysis of cholesterol ester accumulation in macrophages by the use of digital imaging fluorescence microscopy.
Atherosclerosis 1990;85(2-3):175-84.
1990: Blankenhorn D H; Alaupovic P; Wickham E; Chin H P; Azen S P
Prediction of angiographic change in native human coronary arteries and aortocoronary bypass grafts. Lipid and nonlipid factors.
Circulation 1990;81(2):470-6.
1990: Dashti N; Smith E A; Alaupovic P
Increased production of apolipoprotein B and its lipoproteins by oleic acid in Caco-2 cells.
Journal of lipid research 1990;31(1):113-23.
1990: Attman P O; Alaupovic P
Pathogenesis of hyperlipidemia in the nephrotic syndrome.
American journal of nephrology 1990;10 Suppl 1():69-75.
1990: Attman P O; Alaupovic P
The role of lipid metabolism in dietary treatment of chronic renal failure.
Contributions to nephrology 1990;81():35-41.
1990: Alaupovic P; Blankenhorn D H
[Determination of potentially atherogenic triglyceride-rich lipoprotein particles]
Klinische Wochenschrift 1990;68 Suppl 22():38-42.
1989: McConathy W J; Alaupovic P; Woolcock N; Laing S P; Powell J; Greenhalgh R
Lipids and apolipoprotein profiles in men with aneurysmal and stenosing aorto-iliac atherosclerosis.
European journal of vascular surgery 1989;3(6):511-4.
1989: Dashti N; Williams D L; Alaupovic P
Effects of oleate and insulin on the production rates and cellular mRNA concentrations of apolipoproteins in HepG2 cells.
Journal of lipid research 1989;30(9):1365-73.
1989: Dashti N; Koren E; Alaupovic P
Identification and partial characterization of discrete apolipoprotein A-containing lipoprotein particles secreted by human hepatoma cell line HepG2.
Biochemical and biophysical research communications 1989;163(1):574-80.
1989: Stein Y; Stein O; Delplanque B; Fesmire J D; Lee D M; Alaupovic P
Lack of effect of probucol on atheroma formation in cholesterol-fed rabbits kept at comparable plasma cholesterol levels.
Atherosclerosis 1989;75(2-3):145-55.
1988: Blackett P; Sarale D C; Fesmire J; Harmon J; Weech P; Alaupovic P
Plasma apolipoprotein C-III levels in children with type I diabetes.
Southern medical journal 1988;81(4):469-73.
1988: Alaupovic P; Tavella M; Bard J M; Wang C S; Attman P O; Koren E; Corder C; Knight-Gibson C; Downs D
Lipoprotein particles in hypertriglyceridemic states.
Advances in experimental medicine and biology 1988;243():289-97.
1988: Attman P O; Gustafson A; Alaupovic P; Wang C S
Lipid metabolism in patients with chronic renal failure in the predialytic phase.
Contributions to nephrology 1988;65():24-32.
1988: Alaupovic P; McConathy W J; Fesmire J; Tavella M; Bard J M
Profiles of apolipoproteins and apolipoprotein B-containing lipoprotein particles in dyslipoproteinemias.
Clinical chemistry 1988;34(8B):B13-27.
1987: Attman P O; Alaupovic P; Gustafson A
Serum apolipoprotein profile of patients with chronic renal failure.
Kidney international 1987;32(3):368-75.
1987: Dashti N; Alaupovic P; Knight-Gibson C; Koren E
Identification and partial characterization of discrete apolipoprotein B containing lipoprotein particles produced by human hepatoma cell line HepG2.
Biochemistry 1987;26(15):4837-46.
1987: Koren E; Alaupovic P; Lee D M; Dashti N; Kloer H U; Wen G
Selective isolation of human plasma low-density lipoprotein particles containing apolipoproteins B and E by use of a monoclonal antibody to apolipoprotein B.
Biochemistry 1987;26(10):2734-40.
1987: Koren E; Puchois P; Alaupovic P; Fesmire J; Kandoussi A; Fruchart J C
Quantification of two different types of apolipoprotein A-I containing lipoprotein particles in plasma by enzyme-linked differential-antibody immunosorbent assay.
Clinical chemistry 1987;33(1):38-43.
1987: Alaupovic P; Tavella M; Fesmire J
Separation and identification of apo-B-containing lipoprotein particles in normolipidemic subjects and patients with hyperlipoproteinemias.
Advances in experimental medicine and biology 1987;210():7-14.
1986: Blackett P R; Holcombe J H; Alaupovic P; Fesmire J D
Plasma lipids and apolipoproteins in a 13-year-old boy with diabetic ketoacidosis and extreme hyperlipidemia.
The American journal of the medical sciences 1986;291(5):342-6.
1986: Koren E; Solter D; Lee D M; Reiner Z; McConathy W J; Dashti N; Alaupovic P
Characterization of a monoclonal antibody that binds equally to all apolipoprotein and lipoprotein forms of human plasma apolipoprotein B. I. Specificity and binding studies.
Biochimica et biophysica acta 1986;876(1):91-100.
1985: McConathy W J; Koren E; Wieland H; Campos E M; Lee D M; Kloer H U; Alaupovic P
Evaluation of immunoaffinity chromatography for isolating human lipoproteins containing apolipoprotein B.
Journal of chromatography 1985;342(1):46-66.
1985: Koren E; Puchois P; McConathy W J; Fesmire J D; Alaupovic P
Quantitative determination of human plasma apolipoprotein A-I by a noncompetitive enzyme-linked immunosorbent assay.
Clinica chimica acta; international journal of clinical chemistry 1985;147(2):85-95.
1985: Wang C S; McConathy W J; Kloer H U; Alaupovic P
Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III.
The Journal of clinical investigation 1985;75(2):384-90.
1985: Dashti N; Wolfbauer G; Alaupovic P
Binding and degradation of human high-density lipoproteins by human hepatoma cell line HepG2.
Biochimica et biophysica acta 1985;833(1):100-10.
1984: Dashti N; Wolfbauer G; Koren E; Knowles B; Alaupovic P
Catabolism of human low density lipoproteins by human hepatoma cell line HepG2.
Biochimica et biophysica acta 1984;794(3):373-84.
1984: Fesmire J D; McConathy W J; Alaupovic P
Use and significance of reference serum as a secondary standard for electroimmunoassay of apolipoprotein A-I.
Clinical chemistry 1984;30(5):712-6.
1983: Nessim S A; Chin H P; Alaupovic P; Blankenhorn D H
Combined therapy of niacin, colestipol, and fat-controlled diet in men with coronary bypass. Effect on blood lipids and apolipoproteins.
Arteriosclerosis (Dallas, Tex.) 1983;3(6):568-73.
1981: Alaupovic P; Schaefer E J; McConathy W J; Fesmire J D; Brewer H B
Plasma apolipoprotein concentrations in familial apolipoprotein A-I and A-II deficiency (Tangier disease).
Metabolism: clinical and experimental 1981;30(8):805-9.
1981: Curry M D; McConathy W J; Fesmire J D; Alaupovic P
Quantitative determination of apolipoproteins C-I and C-II in human plasma by separate electroimmunoassays.
Clinical chemistry 1981;27(4):543-8.
1980: Curry M D; McConathy W J; Fesmire J D; Alaupovic P
Quantitative determination of human apolipoprotein C-III by electroimmunoassay.
Biochimica et biophysica acta 1980;617(3):503-13.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Petar Alaupovic

Research Profile (preview)

Chemicals & Drugs

Disorders

Concepts & Ideas

Procedures

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Petar Alaupovic (preview)

All Publications